Skip to content

Mindfulness-based cognitive therapy for treatment-resistant depression: a pilot study.

Psychotherapy and Psychosomatics July 4, 2008 DOI: 10.1159/000142525 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pilot study Peer reviewed
Population Individuals with treatment-resistant depression
Intervention Mindfulness-based cognitive therapy
Topics Depression Meditation
Key points Mindfulness-based cognitive therapy was associated with improvements in depressive symptoms among individuals with treatment-resistant depression, suggesting potential benefit and supporting further investigation.

Abstract

Mindfulness-based cognitive therapy for treatment-resistant depression: a pilot study.

Comparable studies

Other non-randomized and open-label trials on depression, most cited first.

Study Year Design Participants
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Patients with moderate-to-severe, unipolar, treatment-resistant major depression 2016 Open-label feasibility trial n = 12
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Patients with severe, unipolar, treatment-resistant major depression 2017 Open-label trial n = 20
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression Patients with recurrent depression 2015 Open-label trial n = 17

Citations in the library

Explore topics